Received 2024-09-02

Revised 2024-09-16

Accepted 2024-10-03

The Challenge of Treating Complex Coronary Lesions: A Call for More Personalized Approaches in Angioplasty

Shirin Allord, Sina Mashayekhi

Cardiovascular Research Center , Tabriz University of Medical Sciences, Tabriz, Iran

Dear Editor,

Treating complex coronary lesions remains a significant challenge in modern interventional cardiology, especially in the context of angioplasty [1]. Despite advances in stent technology and procedural techniques, patients with bifurcation lesions, chronic total occlusions (CTO), and heavily calcified arteries continue to experience higher rates of restenosis, thrombosis, and adverse long-term cardiovascular outcomes [2, 3] it is certainly one of the biggest challenges for interventional cardiologists. Methods. We present a retrospective analysis of patients from our center who underwent percutaneous coronary intervention (PCI). These suboptimal results reveal the need for a more personalized approach to the management of these patients [4].

Current treatment protocols often adopt a one-size-fits-all model that overlooks the critical anatomical variations and unique lesion characteristics of individual patients [4, 5]. Advanced imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), have shown significant potential in improving stent placement and optimizing patient outcomes [6, 7]. A recent systematic review and network meta-analysis demonstrated that IVUS enhances long-term clinical outcomes compared to percutaneous coronary intervention (PCI), particularly by reducing the need for target lesion revascularization [8] IVUS, and OCT. The 2 coprimary outcomes were target lesion revascularization and myocardial infarction. The secondary outcomes included ischemia-driven target lesion revascularization, target vessel myocardial infarction, death, cardiac death, target vessel revascularization, stent thrombosis, and major adverse cardiac events. Frequentist random-effects network meta-analyses were conducted. The results were replicated by Bayesian random-effects models. Pairwise meta-analyses of the direct components, multiple sensitivity analyses, and pairwise meta-analyses IVI versus ICA were supplemented.RESULTS:The results from 24 randomized trials (15 489 patients: IVUS versus ICA, 46.4%, 7189 patients; OCT versus ICA, 32.1%, 4976 patients; OCT versus IVUS, 21.4%, 3324 patients). Also, a study by Ziad et al. reported that OCT guidance led to a greater minimum stent area compared to angiography guidance [9]. However, these tools are underutilized in routine practice [10]. Incorporating these imaging modalities into personalized treatment plans could enhance procedural accuracy and reduce the risk of complications [11].

Emerging research underscores the value of tailored treatment strategies. For instance, hybrid revascularization techniques and drug-eluting balloon therapy have demonstrated promise in treating complex lesions [12–14]. However, the inconsistent application of these methods, coupled with a lack of specific guidelines, has limited their broader adoption. It is imperative that interventional cardiology moves toward developing precise, patient-specific treatment strategies, leveraging these emerging technologies [13, 15] further large-scale randomized controlled trials (RCTs).

Future research should prioritize the integration of advanced imaging techniques and personalized treatment into clinical practice [15] further large-scale randomized controlled trials (RCTs). Systematically incorporating these tools will allow for therapies that address the unique characteristics of each patient’s coronary lesions, ultimately improving long-term outcomes and reducing the risk of adverse events [12, 15] alone or in combination with drug-eluting stents (DES).

We urge professional societies and regulatory bodies to update clinical guidelines and prioritize research that supports the transition toward precision medicine in angioplasty. This shift toward personalized approaches is essential not only for improving procedural outcomes but also for reducing complications and enhancing long-term survival rates. Ultimately, this transition will streamline resources, reduce healthcare costs, and significantly improve patient quality of life.

Conflict of Interest

The authors have no competing interests to declare that are relevant to the content of this article. [GMJ.2024;13:e3607]

DOI:3607

Keywords: Coronary Artery Disease; Angioplasty; Coronary Vessels; Stents; Precision Medicine

GMJ

Copyright© 2024, Galen Medical Journal.

This is an open-access article distributed

under the terms of the Creative Commons

Attribution 4.0 International License

(http://creativecommons.org/licenses/by/4.0/)

Email:gmj@salviapub.com

Correspondence to:

Sina Mashayekhi, Cardiovascular Research Center , Tabriz University of Medical Sciences, Tabriz, Iran.

Telephone Number: +984133373920

Email Address: sinamashayeshi85@gmail.com

GMJ.2024;13:e3607

www.salviapub.com

Allord SH, et al.

The Challenge of Treating Complex Coronary Lesions

2

GMJ.2024;13:e3607

www.salviapub.com

References

  1. Werner N, Nickenig G, Sinning JM. Complex PCI procedures: challenges for the interventional cardiologist. Clin Res Cardiol. 2018 Aug;107(S2):64–73.
  2. Mashayekhi KA, Pyxaras SA, Werner GS, Galassi AR, Garbo R, Boudou N, et al. Contemporary issues of percutaneous coronary intervention in heavily calcified chronic total occlusions: an expert review from the European CTO Club. EuroIntervention. 2023 Jun;19(2):e113–22.
  3. Juricic S, Tesic M, Dobric M, Stojkovic S. Bifurcation lesions in the context of a PCI CTO - insight from Belgrade single center CTO registry. Vojnosanit Pregl. 2023;80(8):685–90.
  4. Andò G, Alagna G, De Rosa S, Pelliccia F, Gragnano F, Niccoli G, et al. Severely calcified coronary artery lesions: focus on interventional management. VESSEL PLUS. 2023;7.
  5. Chaddad R, El-Mokdad R, Lazar L, Cortese B. DCBs as an adjuvant tool to DES for very complex coronary lesions. Rev Cardiovasc Med. 2022 Jan 14;23(1):1.
  6. Kang DY, Ahn JM, Yun SC, Hur SH, Cho YK, Lee CH, et al. Optical Coherence Tomography–Guided or Intravascular Ultrasound–Guided Percutaneous Coronary Intervention: The OCTIVUS Randomized Clinical Trial. Circulation. 2023 Oct 17;148(16):1195–206.
  7. Capodanno D, Spagnolo M. Optical Coherence Tomography or Intravascular Ultrasound for Complex PCI. J Am Coll Cardiol. 2024 Jan;83(3):414–6.
  8. Giacoppo D, Laudani C, Occhipinti G, Spagnolo M, Greco A, Rochira C, et al. Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. Circulation. 2024 Apr 2;149(14):1065–86.
  9. Ali ZA, Landmesser U, Maehara A, Matsumura M, Shlofmitz RA, Guagliumi G, et al. Optical Coherence Tomography–Guided versus Angiography-Guided PCI. N Engl J Med. 2023 Oct 19;389(16):1466–76.
  10. Park DY, Vemmou E, An S, Nikolakopoulos I, Regan CJ, Cambi BC, et al. Trends and impact of intravascular ultrasound and optical coherence tomography on percutaneous coronary intervention for myocardial infarction. IJC Heart Vasc. 2023 Apr 1;45:101186.
  11. Moras E, Gandhi K, Isath A, Wu L, Casso Dominguez A. Trends and outcomes of intravascular imaging in patients undergoing percutaneous coronary intervention for coronary chronic total occlusion: a 5-year retrospective analysis. Eur Heart J. 2023 Nov 9;44(Supplement_2):ehad655.2113.
  12. Yang X, Lu W, Pan L, Han Z, Pan S, Wang X, et al. Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions. Front Cardiovasc Med. 2022 Sep 23;9:935263.
  13. Fu Y, Gao J, Zuo K, Hua C, Yang Y, Liu X, et al. Drug-coated balloons: A better revascularization strategy in patients with multivessel coronary artery disease undergoing one-stop hybrid coronary revascularization surgery. Kardiol Pol. 2023 Nov 30;81(11):1122–9.
  14. Willard R, Scheinerman J, Pupovac S, Patel NC. The Current State of Hybrid Coronary Revascularization. Ann Thorac Surg. 2024 Aug;118(2):318–28.
  15. Tommasino A, Navarra EM, Dell’Aquila F, Ciani C, Fiorentini V, Amicizia S, et al. Hybrid Coronary Revascularization in Multivessel Disease: The Ideal Strategy for Challenging Scenarios. Heart Surg Forum. 2024 Jun 23;27(6):E689–700.

The Challenge of Treating Complex Coronary Lesions

Allord SH, et al.

GMJ.2024;13:e3607

www.salviapub.com

3